AGT can help guide interested parties to the trial sites. These sites will then consider the clinical trial applicants during the recruitment phase.
As a standard practice, drug developers like AGT are not allowed to choose clinical trial participants. The trial sites, which are independent of AGT, are in charge of recruiting for these clinical trials instead. When a new trial opens and recruitment begins, AGT will release news on the event, and provide guidance on how to get in touch with the trial sites. The decision on which applicants to accept into the clinical trial will then fall upon the trial sites based on the study's inclusion and exclusion criteria.